Overview
Robert Ross is an Oncologist practicing medicine in Boston, Massachusetts.
His clinical expertise encompasses Urothelial Cancer and Prostate Cancer.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Prostatectomy. Dr. Choueiri is currently accepting new patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Frequently Asked Questions about Dr. Robert W. Ross
How do I make an appointment with Dr. Robert W. Ross?
You can book an appointment with Dr. Robert W. Ross by calling their office at 617-632-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Robert W. Ross a top-rated expert for Urothelial Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert W. Ross is classified as an Experienced expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Robert W. Ross specialize in?
While Dr. Robert W. Ross is a Oncology, they have specific expertise in Urothelial Cancer, Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Robert W. Ross participate in research or clinical trials?
Yes. Dr. Robert W. Ross has published 8 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Dr. Robert W. Ross's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Robert W. Ross accept my insurance?
Dr. Robert W. Ross accepts most major insurance plans, including Cigna and Tufts. We recommend calling the office directly at 617-632-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Prostate CancerDr. Ross isExperienced. Learn about Prostate Cancer.
- Urothelial CancerDr. Ross isExperienced. Learn about Urothelial Cancer.